Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases

Hee Yun Suk, Chen Zhou, Teddy T C Yang, Hong Zhu, Raymond Y L Yu, Opeyemi Olabisi, Xiao Yong Yang, Deborah Brancho, Ja Young Kim, Philipp E. Scherer, Philippe G. Frank, Michael P. Lisanti, John W. Calvert, David J. Lefer, Jeffery D. Molkentin, Alessandra Ghigo, Emilio Hirsch, Jianping Jin, Chi Wing Chow

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating β-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin Aβ (CnAβ-/-). We show that mice lacking calcineurin Aβ are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnAβ-/- mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by β-adrenergic G-protein-coupled receptor signaling pathways. CnAβ-/- mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnAβ-/- mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnAβ-/- mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.

Original languageEnglish (US)
Pages (from-to)3477-3488
Number of pages12
JournalJournal of Biological Chemistry
Volume288
Issue number5
DOIs
StatePublished - Feb 1 2013

Fingerprint

Calcineurin
Phosphoric Diester Hydrolases
Ablation
Hyperlipidemias
Cyclosporine
Insulin Resistance
Transplants
Homeostasis
Insulin
Lipids
Chemical activation
Type 3 Cyclic Nucleotide Phosphodiesterases
Type 4 Cyclic Nucleotide Phosphodiesterase
Adipokines
Phosphodiesterase Inhibitors
Lipolysis
Cell growth
Transcription
Immunosuppressive Agents
G-Protein-Coupled Receptors

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Suk, H. Y., Zhou, C., Yang, T. T. C., Zhu, H., Yu, R. Y. L., Olabisi, O., ... Chow, C. W. (2013). Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. Journal of Biological Chemistry, 288(5), 3477-3488. https://doi.org/10.1074/jbc.M112.419150

Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. / Suk, Hee Yun; Zhou, Chen; Yang, Teddy T C; Zhu, Hong; Yu, Raymond Y L; Olabisi, Opeyemi; Yang, Xiao Yong; Brancho, Deborah; Kim, Ja Young; Scherer, Philipp E.; Frank, Philippe G.; Lisanti, Michael P.; Calvert, John W.; Lefer, David J.; Molkentin, Jeffery D.; Ghigo, Alessandra; Hirsch, Emilio; Jin, Jianping; Chow, Chi Wing.

In: Journal of Biological Chemistry, Vol. 288, No. 5, 01.02.2013, p. 3477-3488.

Research output: Contribution to journalArticle

Suk, HY, Zhou, C, Yang, TTC, Zhu, H, Yu, RYL, Olabisi, O, Yang, XY, Brancho, D, Kim, JY, Scherer, PE, Frank, PG, Lisanti, MP, Calvert, JW, Lefer, DJ, Molkentin, JD, Ghigo, A, Hirsch, E, Jin, J & Chow, CW 2013, 'Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases', Journal of Biological Chemistry, vol. 288, no. 5, pp. 3477-3488. https://doi.org/10.1074/jbc.M112.419150
Suk, Hee Yun ; Zhou, Chen ; Yang, Teddy T C ; Zhu, Hong ; Yu, Raymond Y L ; Olabisi, Opeyemi ; Yang, Xiao Yong ; Brancho, Deborah ; Kim, Ja Young ; Scherer, Philipp E. ; Frank, Philippe G. ; Lisanti, Michael P. ; Calvert, John W. ; Lefer, David J. ; Molkentin, Jeffery D. ; Ghigo, Alessandra ; Hirsch, Emilio ; Jin, Jianping ; Chow, Chi Wing. / Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. In: Journal of Biological Chemistry. 2013 ; Vol. 288, No. 5. pp. 3477-3488.
@article{fe9e2eeed0594234b529b225148c8b4b,
title = "Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases",
abstract = "Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating β-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin Aβ (CnAβ-/-). We show that mice lacking calcineurin Aβ are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnAβ-/- mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by β-adrenergic G-protein-coupled receptor signaling pathways. CnAβ-/- mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnAβ-/- mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnAβ-/- mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.",
author = "Suk, {Hee Yun} and Chen Zhou and Yang, {Teddy T C} and Hong Zhu and Yu, {Raymond Y L} and Opeyemi Olabisi and Yang, {Xiao Yong} and Deborah Brancho and Kim, {Ja Young} and Scherer, {Philipp E.} and Frank, {Philippe G.} and Lisanti, {Michael P.} and Calvert, {John W.} and Lefer, {David J.} and Molkentin, {Jeffery D.} and Alessandra Ghigo and Emilio Hirsch and Jianping Jin and Chow, {Chi Wing}",
year = "2013",
month = "2",
day = "1",
doi = "10.1074/jbc.M112.419150",
language = "English (US)",
volume = "288",
pages = "3477--3488",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases

AU - Suk, Hee Yun

AU - Zhou, Chen

AU - Yang, Teddy T C

AU - Zhu, Hong

AU - Yu, Raymond Y L

AU - Olabisi, Opeyemi

AU - Yang, Xiao Yong

AU - Brancho, Deborah

AU - Kim, Ja Young

AU - Scherer, Philipp E.

AU - Frank, Philippe G.

AU - Lisanti, Michael P.

AU - Calvert, John W.

AU - Lefer, David J.

AU - Molkentin, Jeffery D.

AU - Ghigo, Alessandra

AU - Hirsch, Emilio

AU - Jin, Jianping

AU - Chow, Chi Wing

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating β-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin Aβ (CnAβ-/-). We show that mice lacking calcineurin Aβ are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnAβ-/- mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by β-adrenergic G-protein-coupled receptor signaling pathways. CnAβ-/- mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnAβ-/- mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnAβ-/- mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.

AB - Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating β-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin Aβ (CnAβ-/-). We show that mice lacking calcineurin Aβ are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnAβ-/- mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by β-adrenergic G-protein-coupled receptor signaling pathways. CnAβ-/- mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnAβ-/- mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnAβ-/- mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=84873294364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873294364&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.419150

DO - 10.1074/jbc.M112.419150

M3 - Article

VL - 288

SP - 3477

EP - 3488

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 5

ER -